Rajive Kumar

1.4k total citations
96 papers, 973 citations indexed

About

Rajive Kumar is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rajive Kumar has authored 96 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Hematology, 27 papers in Genetics and 21 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rajive Kumar's work include Acute Myeloid Leukemia Research (31 papers), Acute Lymphoblastic Leukemia research (17 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Rajive Kumar is often cited by papers focused on Acute Myeloid Leukemia Research (31 papers), Acute Lymphoblastic Leukemia research (17 papers) and Chronic Myeloid Leukemia Treatments (16 papers). Rajive Kumar collaborates with scholars based in India, United States and Australia. Rajive Kumar's co-authors include Anil Suri, Anju Gupta, Sameer Bakhshi, Mona Anand, Paresh Jain, Deepika Kanojia, Anita Chopra, Manoj Garg, Nirmala Jagadish and Nirmal Kumar Lohiya and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Rajive Kumar

91 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajive Kumar India 19 351 328 170 163 151 96 973
Michael A. Linden United States 20 562 1.6× 582 1.8× 141 0.8× 165 1.0× 137 0.9× 88 1.3k
Kaoru Kahata Japan 19 379 1.1× 315 1.0× 97 0.6× 164 1.0× 59 0.4× 73 1.3k
Albert N. Békássy Sweden 18 249 0.7× 541 1.6× 336 2.0× 135 0.8× 126 0.8× 36 1.1k
Cristina Arbona Spain 18 259 0.7× 630 1.9× 174 1.0× 251 1.5× 294 1.9× 53 1.3k
Khalid Tobal United Kingdom 20 634 1.8× 751 2.3× 282 1.7× 138 0.8× 118 0.8× 40 1.3k
A Zander Germany 17 317 0.9× 465 1.4× 87 0.5× 273 1.7× 108 0.7× 51 1.1k
Yoshihisa Nagatoshi Japan 18 138 0.4× 359 1.1× 185 1.1× 151 0.9× 97 0.6× 54 889
Paolo Peterlongo Italy 13 450 1.3× 198 0.6× 64 0.4× 206 1.3× 75 0.5× 31 1.0k
Atsushi Kikuta Japan 21 212 0.6× 654 2.0× 228 1.3× 337 2.1× 145 1.0× 118 1.5k
M. Freund Germany 15 221 0.6× 532 1.6× 98 0.6× 187 1.1× 294 1.9× 47 1.1k

Countries citing papers authored by Rajive Kumar

Since Specialization
Citations

This map shows the geographic impact of Rajive Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajive Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajive Kumar more than expected).

Fields of papers citing papers by Rajive Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajive Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajive Kumar. The network helps show where Rajive Kumar may publish in the future.

Co-authorship network of co-authors of Rajive Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Rajive Kumar. A scholar is included among the top collaborators of Rajive Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajive Kumar. Rajive Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Rajive, Sameer Bakhshi, Atul Sharma, et al.. (2024). Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression. Asian Pacific Journal of Cancer Prevention. 25(7). 2283–2289.
2.
Chopra, Anita, Haraprasad Pati, Sameer Bakhshi, et al.. (2016). Nucleophosmin mutation analysis in acute myeloid leukaemia. The Indian Journal of Medical Research. 143(6). 763–768. 10 indexed citations
3.
Sharma, Atul, et al.. (2015). Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma. Indian Journal of Hematology and Blood Transfusion. 32(1). 10–17. 10 indexed citations
4.
Iqbal, Nida, Atul Sharma, Vinod Raina, et al.. (2014). Poor Response to Standard Chemotherapy in Early T-precursor (ETP)-ALL: A Subtype of T-ALL Associated with Unfavourable Outcome: A Brief Report. Indian Journal of Hematology and Blood Transfusion. 30(4). 215–218. 7 indexed citations
5.
Chopra, Anita, Rajive Kumar, Kamal Kishore, et al.. (2012). Effect of glucocorticoids on von Willebrand factor levels and its correlation with von Willebrand factor gene promoter polymorphism. Blood Coagulation & Fibrinolysis. 23(6). 514–519. 13 indexed citations
6.
Singhal, Manish, Sarika Singh, Rajive Kumar, & Vinod Raina. (2010). Extensive cutaneous manifestations: Presenting feature of chronic myelocytic leukemia in second blast crisis. Indian Journal of Dermatology. 55(3). 265–265. 4 indexed citations
7.
Kanojia, Deepika, Manoj Garg, Shikha Saini, et al.. (2010). Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia. Leukemia Research. 34(7). 858–863. 19 indexed citations
8.
Arora, Narendra K., Prashant Mathur, Manoja Kumar Das, et al.. (2010). Alpha 1 antitrypsin deficiency in children with chronic liver disease in North India. Indian Pediatrics. 47(12). 1015–1023. 19 indexed citations
9.
Raina, Vinod, Lalit Kumar, Atul Sharma, et al.. (2010). Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country. Leukemia & lymphoma. 51(10). 1850–1854. 9 indexed citations
10.
Kannan, Meganathan, Firdos Ahmad, Birendra Kumar Yadav, et al.. (2009). Glanzmann's thrombasthenia in North Indians: Sub classification and carrier detection by flow cytometry. Platelets. 20(1). 12–15. 10 indexed citations
11.
Garg, Manoj, Deepika Kanojia, Aashima Khosla, et al.. (2008). Sperm-Associated Antigen 9 Is Associated With Tumor Growth, Migration, and Invasion in Renal Cell Carcinoma. Cancer Research. 68(20). 8240–8248. 70 indexed citations
12.
Sankar, Jhuma, et al.. (2008). Unusual lymphocytosis with systemic lupus erythematosus. The Indian Journal of Pediatrics. 75(7). 748–750. 2 indexed citations
13.
Kumar, Rajive, et al.. (2008). Subcutaneous Panniculitislike T-cell Lymphoma With Hemophagocytosis: Complete Remission With BFM-90 Protocol. Journal of Pediatric Hematology/Oncology. 30(7). 558–561. 20 indexed citations
14.
Anand, Mona, Rajive Kumar, Sarika Singh, et al.. (2005). Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia. Annals of Hematology. 84(12). 767–770. 7 indexed citations
15.
16.
Deo, Suryanarayana, Atul Samaiya, Sonal Asthana, et al.. (2004). Sentinel Lymph Node Biopsy Assessment Using Intraoperative Imprint Cytology in Breast Cancer Patients: Results of a Validation Study. Asian Journal of Surgery. 27(4). 294–298. 18 indexed citations
17.
Raina, Vinod, et al.. (2003). Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease.. PubMed. 16(4). 199–203. 5 indexed citations
18.
Anand, Mona, Rajive Kumar, Paresh Jain, et al.. (2003). Metastatic Anaplastic Oligodendroglioma Simulating Acute Leukemia. Acta Cytologica. 47(3). 467–469. 21 indexed citations
19.
20.
Kumar, Rajive, et al.. (1989). Coexisting Hereditary Methaemoglobinaemia and Heterozygous β‐Tialassaemia. Acta Paediatrica. 78(1). 149–151.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Linden Breakdown of academic impact, for papers by Kaoru Kahata Breakdown of academic impact, for papers by Albert N. Békássy Breakdown of academic impact, for papers by Cristina Arbona Breakdown of academic impact, for papers by Khalid Tobal Breakdown of academic impact, for papers by A Zander Breakdown of academic impact, for papers by Yoshihisa Nagatoshi Breakdown of academic impact, for papers by Paolo Peterlongo Breakdown of academic impact, for papers by Atsushi Kikuta Breakdown of academic impact, for papers by M. Freund
Rankless by CCL
2026